3 -Adrenoceptor agonists: potential, pitfalls and progress

By Arch J.R.S.  

European Journal of Pharmacology, Vol. 440, Iss. 2, 2002-04 ,pp. : 99-107

Elsevier

Access to resources Recommend Favorite

Beta3 -Adrenoceptor Agonists as Anti-diabetic and Anti-obesity Drugs in Humans

By  

Current Pharmaceutical Design, Vol. 7, Iss. 14, 2001-09 ,pp. : 1433-1449

Bentham Science Publishers

Access to resources Recommend Favorite

Drug enhancement of memory consolidation: historical perspective and neurobiological implications

By McGaugh James   Roozendaal Benno  

Psychopharmacology, Vol. 202, Iss. 1-3, 2009-01 ,pp. : 3-14

Springer Publishing Company

Access to resources Recommend Favorite

Influence of -adrenoceptor agonists on the pulmonary circulation. Effects of a 3 -adrenoceptor antagonist, SR 59230A

By Dumas M.   Dumas J.-P.   Bardou M.   Rochette L.   Advenier C.   Giudicelli J.-F.  

European Journal of Pharmacology, Vol. 348, Iss. 2, 1998-05 ,pp. : 223-228

Elsevier

Access to resources Recommend Favorite

Effects of -adrenoceptor agonists and antagonists on histamine-induced impairment of memory retention of passive avoidance learning in rats

By Zarrindast M.-R.   Ahmadi R.   Oryan S.   Parivar K.   Haeri-Rohani A.  

European Journal of Pharmacology, Vol. 454, Iss. 2, 2002-11 ,pp. : 193-198

Elsevier

Access to resources Recommend Favorite